Angels for Change Presents Annual Drug Shortage Guardian Award to STAQ Pharma
Tampa, FL - [June 29th, 2023] -- Angels for Change, a global non-profit on a mission to end drug shortages, has presented the organization’s Annual Drug Shortage Guardian Award to STAQ Pharma, a leading pharmaceutical 503B Outsourcing Facility with operating facilities in both in Denver, CO and Columbus, OH.
STAQ Pharma received the award in recognition of their exceptional work in serving pediatric patients during the 2022 Potassium Chloride and Sodium Chloride drug shortage. Their collaborative, patient-focused, proactive, and innovative work led to 700,000 life-saving patient treatments accessed across the United States during a drug shortage and the creation of the Angels for Change Project PROTECT program.
The Drug Shortage Guardian Award is presented annually to an organization, and its people, exhibiting exceptional patient-centered work during a drug shortage crisis. Angels for Change defines a guardian as a “Defender; one that Guards, Protects those in need”.
In addition to recognizing STAQ Pharma, Angels for Change also presented individual Drug Shortage Guardian Awards to the following frontline STAQ employees: Lou Thao, Dmitriy Gekker , Amy Shepard, Bryce Gode, MacKenzie McComber, Veronica Landin, Divine Apongo , Tai Quetschenbach, Fue Xiong, Rosemary Ramirez, Evan Brunick, Victoria Long, Patrick Griffith, Travis Garlock, Carla Ortega, and Tanya Flenory.
Each of these guardians' extraordinary work exceeded their normal tasks and directly contributed to 700,000, life-saving patient treatments accessed. Their heroic efforts included the development and production of two essential medicines before a shortage and the delivery of those essential medicines to customers during a shortage.
The awards were given in Denver, CO on June 29th with STAQ leaders Joe Bagan, Chief Executive Officer; Mark Spiecker, President; and Jeff Hval, Chief Operations Officer joining Angels for Change founder Laura Bray during the award presentation.
“Recognizing individuals, within the supply chain, for above and beyond patient-focused work is important to fostering the change needed to build a resilient supply chain. We are proud to give this award to these amazing team members who we worked closely with for over 12 months. The lives that were saved because of this work cannot be measured. How do we measure one life-saving treatment accessed, let alone 700,000? Our country has been changed for the better because of the lives saved in this project and none of this could have happened without STAQ Pharma, its leaders and employees.” said Laura Bray, founder, and Chief Change Maker of Angels for Change.
Can you help protect patients from shortage? Contact us at communications@angelsforchange.org and join the race to end drug shortages!
About Angels for Change
Angels for Change is a volunteer supported, global, 501c3 organization started in Tampa, FL on a mission to end drug shortages through advocacy, awareness, and a resilient supply chain. Founder, Laura Bray, was driven to start Angels for Change after her own child faced 3 life-saving drug shortages in 9 months of pediatric cancer treatment. Each day Angels for Change advocates on behalf of any patient in a life-saving drug shortage, while building relationships with patients and members of the pharmaceutical supply chain to end all healthcare crises created by drug shortages. www.angelsforchange.org
About STAQ Pharma Inc.
STAQ Pharma (Safety, Transparency, Availability, Quality) is a 503B Outsourcing facility headquartered in Denver, CO. STAQ is a CGMP manufacturing facility designed to produce compounded medications in prefilled syringes and IV bags for anesthesia and surgical procedures. STAQ produces sterile to sterile and non-sterile to sterile and relies heavily on automation, ensuring adequate supply and compliance with FDA regulations. STAQ is focused on adult and pediatrics, to ensure that our biggest and littlest patients get the right dose at the right concentrations. You can learn more about us at www.staqpharma.com.